By Sabine Waldeck
The US Food and Drug Administration (FDA) has launched a public dashboard for consumers to access and report cosmetics that they believe to have exhibited adverse effects. The interactive tool aims to increase government–constituent transparency.
The FDA Adverse Event Reporting System (FAERS) Public Dashboard for Cosmetic Products is designed to facilitate the public’s access to “real-time” event data on cosmetic products.
The move is part of the FDA’s modernization strategy under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).
“Adverse event reporting should be fast, seamless, and transparent,” says FDA Commissioner Martin Makary. “People who navigate the government’s clunky adverse event reporting websites should not have to wait months for that information to become public. We’re closing that waiting period and will continue to streamline the process from start to finish.”
The FDA has issued a disclaimer that it does not verify reports in the dashboard and that their publication does not indicate that it has concluded that the product caused the adverse event. Additionally, the FAERS data is not an indicator of the cosmetic product’s overall safety profile.
